RESEARCH STARTER
Streptococcus pyogenes
Streptococcus pyogenes, commonly referred to as Group A streptococcus, is a type of bacteria known for being a significant human pathogen. It can be found in healthy individuals, with around 15% of people carrying it asymptomatically, mainly in the respiratory tract. Despite its presence in healthy individuals, S. pyogenes is responsible for a variety of infections, ranging from mild, such as strep throat and impetigo, to severe and potentially life-threatening conditions like necrotizing fasciitis and toxic shock syndrome. The bacterium's ability to rapidly colonize and multiply in hosts is a key factor in its pathogenicity.
S. pyogenes is a gram-positive bacterium characterized by its spherical shape and chain-like formations. It has a protective capsule that helps it evade the immune system, and its cell wall contains proteins that facilitate adherence to host tissues. While many infections caused by S. pyogenes are easily treatable with antibiotics, the bacterium can still lead to serious health complications if not addressed promptly. Understanding the characteristics and potential health impacts of S. pyogenes is essential for effective prevention and treatment of infections it may cause.
Authored By: Lasky, Jack 1 of 4
Published In: 2017 2 of 4
- Related Topics:
3 of 4
- Related Articles:Different Presentations of Invasive Streptococcus pyogenes Infections in Children.;Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections.;Supervening Abscess Resulting in Streptococcus pyogenes Toxic Shock Syndrome Complicated by a Recent MRSA Infection in an Active Duty Military Member.
4 of 4
Full Article
Streptococcus pyogenes (S. pyogenes) is a species of bacteria that is one of the most common disease-causing pathogens in humans. S. pyogenes is often present even in healthy individuals. Asymptomatic pharyngeal carriage of S. pyogenes varies by population and has been reported in healthy children. Nevertheless, the S. pyogenes bacterium is a major cause of human disease. This is because the bacterium is capable of rapidly colonizing and multiplying within a host. Such rapid growth subsequently contributes to the development of an array of possible acute infections. While some of these possible infections, such as strep throat and impetigo, are relatively innocuous, some, like necrotizing fasciitis, can be life-threatening. Estimates suggest that S. pyogenes is responsible for causing about ten million minor throat and skin infections every year. S. pyogenes remains susceptible to penicillin, and many infections can be treated with antibiotics, though invasive infections can be severe and require urgent care.
Background
The Streptococcus family of bacteria was first described by German-Austrian physician Theodor Billroth in the nineteenth century. Billroth made his historic breakthrough when he discovered S. pyogenes growing in his patients’ infected wounds. S. pyogenes was formally named by German physician Michael Joseph Rossbach in 1884. The name pyogenes is taken from the Greek term for “pus-forming.” American researcher Rebecca Lancefield officially classified S. pyogenes as a group A streptococcus in the 1930s. Group A was one of several alphabetically labeled groups into which different strains of streptococci are categorized. In recognition of her accomplishments, these groups are commonly referred to as the Lancefield groups. In addition to classifying S. pyogenes as a group A streptococcus, Lancefield also discovered the critical role that M protein, a special protein found in the cell walls of all group A streptococci, plays in S. pyogenes’ ability to cause disease. The emm typing, based on the gene that encodes the M protein, is used to distinguish among more than 275 types of S. pyogenes.
In medicine, S. pyogenes initially came to be known among physicians as the cause of puerperal fever. Puerperal fever was a potentially life-threatening infection that often occurred in women shortly after childbirth. This disease was a common cause of childbirth-related deaths until nineteenth-century German Hungarian physician Ignaz Semmelweis discovered that it could be prevented if doctors simply washed their hands before performing vaginal examinations. Scarlet fever was another disease commonly caused by S. pyogenes infection before the advent of modern antibiotic therapy. However, in 2023 and 2024, the incidence of pediatric scarlet fever reached high numbers in two decades in the United States, with the numbers tapering by the start of 2025.
S. pyogenes is a gram-positive bacterium. Gram-positive bacteria have an especially thick cell wall made of a protein known as peptidoglycan. In gram-negative bacteria, peptidoglycan is found only in a small layer of the cell wall that is sandwiched between the inner and outer cell membranes. While gram-positive bacteria are often considered to be helpful and gram-negative bacteria are often considered harmful, neither of these assertions is entirely correct. Many gram-positive bacteria, including S. pyogenes, can cause disease. Similarly, some gram-negative bacteria can actually be beneficial for the human body.
Overview
S. pyogenes has a number of key characteristics that make it easy to identify. On a microscopic level, S. pyogenes appears to be a spherical bacterium that occurs in long, chain-like formations. In addition, S. pyogenes is a facultative anaerobic bacterium, which means that it can grow in an environment with or without oxygen. Studies have shown, in fact, that the growth of S. pyogenes is actually stimulated by the presence of carbon dioxide.
The virulence, or potential harmfulness, of S. pyogenes is determined by several different factors. Most importantly, S. pyogenes contains a special capsule that provides it with the ability to disguise itself from white blood cells. This means that it is difficult for the immune system to fight a S. pyogenes infection on its own. Further, the cell walls of S. pyogenes bacteria contain special proteins that allow it to adhere to the epithelial cells that make up skin. S. pyogenes bacteria are also capable of producing enzymes that help it to destroy tissue and spread. On top of all that, S. pyogenes bacteria is also able to produce mild toxins that cause rashes and other minor symptoms, as well as more dangerous toxins that can trigger organ failure.
S. pyogenes bacteria can cause a wide variety of diseases. Chief among these is streptococcal pharyngitis. Known more commonly as strep throat, streptococcal pharyngitis is the leading cause of bacterial sore throats and often results in a low-grade fever, a scratchy red throat with draining white patches, and swollen lymph nodes. Younger patients may also present with a headache or stomach ache. In some cases, strep throat may also be accompanied by rheumatic fever, an inflammatory condition that affects the skin, joints, heart, and nervous system.
Another disease caused by S. pyogenes bacteria is impetigo. Impetigo is a superficial skin infection that commonly occurs in children. The most common symptoms include the appearance of pustules and reddened skin around the arms, hands, or face. Impetigo may also lead to the appearance of itchy sores that ooze and form yellow crust.
S. pyogenes can also cause cellulitis, an infection that usually enters the body through cuts or scrapes in the skin. Cellulitis affects the deepest layers of the skin. It occurs most often on the face or legs. The skin around the infection site typically appears red and hot to the touch. Other symptoms of cellulitis include swollen skin, fever, chills, sweating, weakness, and shock.
Among the most serious conditions that S. pyogenes bacteria can cause is necrotizing fasciitis. Necrotizing fasciitis is a flesh-eating disease that occurs when bacteria enter the body and release a harmful toxin that destroys skin and other tissues. The damage caused by necrotizing fasciitis can spread quickly and may rapidly lead to death if it cannot be contained. S. pyogenes infections can also lead to toxic shock syndrome, a serious condition that occurs in response to an infection somewhere in the body. Toxic shock syndrome often results in fever, low blood pressure, kidney and liver failure, difficulty breathing, confusion, and bleeding problems. In severe cases, it may also lead to shock and death.
Bibliography
“Clinical Considerations for Group A Streptococcus.” Centers for Disease Control and Prevention, www.cdc.gov/group-a-strep/hcp/clinical-guidance/index.html. Accessed 28 May 2026.
“Group A Streptococcus.” Centers for Disease Control and Prevention, www.cdc.gov/infection-control/hcp/healthcare-personnel-epidemiology-control/group-a-streptococcus.html. Accessed 28 May 2026.
Hung, Te-Yu, et al. “Antibiotics to Eradicate Streptococcus Pyogenes Pharyngeal Carriage in Asymptomatic Children and Adults: A Systematic Review.” Journal of Infection, vol. 88, no. 3, Mar. 2024, doi:10.1016/j.jinf.2024.01.003. Accessed 28 May 2026.
Keuleyan, Emma et al. “Characterization of Streptococcus pyogenes Strains from Tonsillopharyngitis and Scarlet Fever Resurgence, 2023-FIRST Detection of M1UK in Bulgaria.” Microorganisms, vol. 13, no. 1, 16 Jan. 2025, doi:10.3390/microorganisms13010179. Accessed 28 May 2026.
Khan, Zartash Zafar. “Group A Streptococcal (GAS) Infections.” Medscape, 8 Aug. 2017, emedicine.medscape.com/article/228936-overview. Accessed 28 May 2026.
“Streptococcal Skin Infection.” DermNet New Zealand, www.dermnetnz.org/topics/streptococcal-skin-infections. Accessed 28 May 2026.
“Streptococcus Pyogenes.” MSDSonline, www.msdsonline.com/resources/msds-resources/free-safety-data-sheet-index/streptococcus-pyogenes. Accessed 28 May 2026.
“Streptococcus Pyogenes.” Pathway Medicine, www.pathwaymedicine.org/streptococcus-pyogenes. Accessed 28 May 2026.
Todar, Kenneth. “Streptococcus Pyogenes and Streptococcal Disease.” Todar’s Online Textbook of Bacteriology, textbookofbacteriology.net/streptococcus.html. Accessed 28 May 2026.
Full Article
Streptococcus pyogenes (S. pyogenes) is a species of bacteria that is one of the most common disease-causing pathogens in humans. S. pyogenes is often present even in healthy individuals. Asymptomatic pharyngeal carriage of S. pyogenes varies by population and has been reported in healthy children. Nevertheless, the S. pyogenes bacterium is a major cause of human disease. This is because the bacterium is capable of rapidly colonizing and multiplying within a host. Such rapid growth subsequently contributes to the development of an array of possible acute infections. While some of these possible infections, such as strep throat and impetigo, are relatively innocuous, some, like necrotizing fasciitis, can be life-threatening. Estimates suggest that S. pyogenes is responsible for causing about ten million minor throat and skin infections every year. S. pyogenes remains susceptible to penicillin, and many infections can be treated with antibiotics, though invasive infections can be severe and require urgent care.
Background
The Streptococcus family of bacteria was first described by German-Austrian physician Theodor Billroth in the nineteenth century. Billroth made his historic breakthrough when he discovered S. pyogenes growing in his patients’ infected wounds. S. pyogenes was formally named by German physician Michael Joseph Rossbach in 1884. The name pyogenes is taken from the Greek term for “pus-forming.” American researcher Rebecca Lancefield officially classified S. pyogenes as a group A streptococcus in the 1930s. Group A was one of several alphabetically labeled groups into which different strains of streptococci are categorized. In recognition of her accomplishments, these groups are commonly referred to as the Lancefield groups. In addition to classifying S. pyogenes as a group A streptococcus, Lancefield also discovered the critical role that M protein, a special protein found in the cell walls of all group A streptococci, plays in S. pyogenes’ ability to cause disease. The emm typing, based on the gene that encodes the M protein, is used to distinguish among more than 275 types of S. pyogenes.
In medicine, S. pyogenes initially came to be known among physicians as the cause of puerperal fever. Puerperal fever was a potentially life-threatening infection that often occurred in women shortly after childbirth. This disease was a common cause of childbirth-related deaths until nineteenth-century German Hungarian physician Ignaz Semmelweis discovered that it could be prevented if doctors simply washed their hands before performing vaginal examinations. Scarlet fever was another disease commonly caused by S. pyogenes infection before the advent of modern antibiotic therapy. However, in 2023 and 2024, the incidence of pediatric scarlet fever reached high numbers in two decades in the United States, with the numbers tapering by the start of 2025.
S. pyogenes is a gram-positive bacterium. Gram-positive bacteria have an especially thick cell wall made of a protein known as peptidoglycan. In gram-negative bacteria, peptidoglycan is found only in a small layer of the cell wall that is sandwiched between the inner and outer cell membranes. While gram-positive bacteria are often considered to be helpful and gram-negative bacteria are often considered harmful, neither of these assertions is entirely correct. Many gram-positive bacteria, including S. pyogenes, can cause disease. Similarly, some gram-negative bacteria can actually be beneficial for the human body.
Overview
S. pyogenes has a number of key characteristics that make it easy to identify. On a microscopic level, S. pyogenes appears to be a spherical bacterium that occurs in long, chain-like formations. In addition, S. pyogenes is a facultative anaerobic bacterium, which means that it can grow in an environment with or without oxygen. Studies have shown, in fact, that the growth of S. pyogenes is actually stimulated by the presence of carbon dioxide.
The virulence, or potential harmfulness, of S. pyogenes is determined by several different factors. Most importantly, S. pyogenes contains a special capsule that provides it with the ability to disguise itself from white blood cells. This means that it is difficult for the immune system to fight a S. pyogenes infection on its own. Further, the cell walls of S. pyogenes bacteria contain special proteins that allow it to adhere to the epithelial cells that make up skin. S. pyogenes bacteria are also capable of producing enzymes that help it to destroy tissue and spread. On top of all that, S. pyogenes bacteria is also able to produce mild toxins that cause rashes and other minor symptoms, as well as more dangerous toxins that can trigger organ failure.
S. pyogenes bacteria can cause a wide variety of diseases. Chief among these is streptococcal pharyngitis. Known more commonly as strep throat, streptococcal pharyngitis is the leading cause of bacterial sore throats and often results in a low-grade fever, a scratchy red throat with draining white patches, and swollen lymph nodes. Younger patients may also present with a headache or stomach ache. In some cases, strep throat may also be accompanied by rheumatic fever, an inflammatory condition that affects the skin, joints, heart, and nervous system.
Another disease caused by S. pyogenes bacteria is impetigo. Impetigo is a superficial skin infection that commonly occurs in children. The most common symptoms include the appearance of pustules and reddened skin around the arms, hands, or face. Impetigo may also lead to the appearance of itchy sores that ooze and form yellow crust.
S. pyogenes can also cause cellulitis, an infection that usually enters the body through cuts or scrapes in the skin. Cellulitis affects the deepest layers of the skin. It occurs most often on the face or legs. The skin around the infection site typically appears red and hot to the touch. Other symptoms of cellulitis include swollen skin, fever, chills, sweating, weakness, and shock.
Among the most serious conditions that S. pyogenes bacteria can cause is necrotizing fasciitis. Necrotizing fasciitis is a flesh-eating disease that occurs when bacteria enter the body and release a harmful toxin that destroys skin and other tissues. The damage caused by necrotizing fasciitis can spread quickly and may rapidly lead to death if it cannot be contained. S. pyogenes infections can also lead to toxic shock syndrome, a serious condition that occurs in response to an infection somewhere in the body. Toxic shock syndrome often results in fever, low blood pressure, kidney and liver failure, difficulty breathing, confusion, and bleeding problems. In severe cases, it may also lead to shock and death.
Bibliography
“Clinical Considerations for Group A Streptococcus.” Centers for Disease Control and Prevention, www.cdc.gov/group-a-strep/hcp/clinical-guidance/index.html. Accessed 28 May 2026.
“Group A Streptococcus.” Centers for Disease Control and Prevention, www.cdc.gov/infection-control/hcp/healthcare-personnel-epidemiology-control/group-a-streptococcus.html. Accessed 28 May 2026.
Hung, Te-Yu, et al. “Antibiotics to Eradicate Streptococcus Pyogenes Pharyngeal Carriage in Asymptomatic Children and Adults: A Systematic Review.” Journal of Infection, vol. 88, no. 3, Mar. 2024, doi:10.1016/j.jinf.2024.01.003. Accessed 28 May 2026.
Keuleyan, Emma et al. “Characterization of Streptococcus pyogenes Strains from Tonsillopharyngitis and Scarlet Fever Resurgence, 2023-FIRST Detection of M1UK in Bulgaria.” Microorganisms, vol. 13, no. 1, 16 Jan. 2025, doi:10.3390/microorganisms13010179. Accessed 28 May 2026.
Khan, Zartash Zafar. “Group A Streptococcal (GAS) Infections.” Medscape, 8 Aug. 2017, emedicine.medscape.com/article/228936-overview. Accessed 28 May 2026.
“Streptococcal Skin Infection.” DermNet New Zealand, www.dermnetnz.org/topics/streptococcal-skin-infections. Accessed 28 May 2026.
“Streptococcus Pyogenes.” MSDSonline, www.msdsonline.com/resources/msds-resources/free-safety-data-sheet-index/streptococcus-pyogenes. Accessed 28 May 2026.
“Streptococcus Pyogenes.” Pathway Medicine, www.pathwaymedicine.org/streptococcus-pyogenes. Accessed 28 May 2026.
Todar, Kenneth. “Streptococcus Pyogenes and Streptococcal Disease.” Todar’s Online Textbook of Bacteriology, textbookofbacteriology.net/streptococcus.html. Accessed 28 May 2026.
More Like ThisRelated Articles
Related Articles (3)
Related Articles (3)
- Different Presentations of Invasive Streptococcus pyogenes Infections in Children.Published In: Clinical Pediatrics, 2025, v. 64, n. 1. P. 14Authored By: Arslan, Asli; Avcu, Gülhadiye; Erci, Ece; Aydemir, Sabire Şöhret; Kurugol, Zafer; Sahbudak Bal, ZumrutPublication Type: Academic Journal
- Serological Responses to Target Streptococcus pyogenes Vaccine Antigens in Patients With Proven Invasive β-Hemolytic Streptococcal Infections.Published In: Journal of Infectious Diseases, 2025, v. 231, n. 4. P. 913Authored By: Langworthy, Kristyn; Taggart, Michael; Smith, Rosemary; Levy, Avram; Knight, Daniel R; Hui, Siong; Fulurija, Alma; Morici, Michael; Raby, Edward; Manning, LaurensPublication Type: Academic Journal
- Supervening Abscess Resulting in Streptococcus pyogenes Toxic Shock Syndrome Complicated by a Recent MRSA Infection in an Active Duty Military Member.Published In: Military Medicine, 2025, v. 190, n. 3/4. P. 886Authored By: Avis, Erik C; Blankinship, Daniel R; Murphy, Timothy P; Lago, Kathryn; Robertson, Janelle L; Nelson, Kenneth JPublication Type: Academic Journal